Hepatoblastoma
ICD-10 C22.2 is a billable code used to indicate a diagnosis of hepatoblastoma.
Hepatoblastoma is a rare malignant tumor of the liver that primarily affects children, typically under the age of 3. It arises from immature liver cells and is characterized by a variety of histological patterns. The tumor can present as a solitary mass or multiple nodules within the liver. Symptoms may include abdominal swelling, pain, jaundice, and elevated alpha-fetoprotein (AFP) levels, which are often used as a tumor marker for diagnosis and monitoring treatment response. Hepatoblastoma is associated with certain genetic syndromes, such as Beckwith-Wiedemann syndrome and familial adenomatous polyposis. Treatment usually involves a combination of surgical resection and chemotherapy, with liver transplantation being considered in cases of unresectable tumors or those with significant liver dysfunction. The prognosis for hepatoblastoma is generally favorable, especially when diagnosed early and treated appropriately.
Detailed clinical notes on tumor characteristics, treatment plans, and response to therapy.
Diagnosis and management of hepatoblastoma, monitoring AFP levels, and planning for potential liver transplantation.
Ensure accurate staging and documentation of associated genetic syndromes.
Operative reports detailing surgical interventions, including resection and transplantation.
Surgical management of hepatoblastoma, including indications for liver transplantation.
Document the rationale for surgical decisions and any complications encountered.
Used in cases where the hepatoblastoma is resectable.
Operative report detailing the extent of resection and any complications.
Pediatric surgical documentation must include indications for surgery and post-operative care.
Indicated for unresectable hepatoblastoma.
Comprehensive documentation of the transplant procedure and post-operative management.
Ensure coordination between oncology and transplant teams.
Hepatoblastoma typically occurs in children under the age of 3, with the majority of cases diagnosed in infants and toddlers.
Diagnosis is made through imaging studies, elevated AFP levels, and histological examination of liver tissue.
Treatment options include surgical resection, chemotherapy, and in some cases, liver transplantation.
